Description
Using our intelligently designed and intuitive dataset, you can quickly understand how Ascendis Pharma, Inc. (ASND) is lobbying the U.S. government, how much they’re spending on it, and most importantly – the bills and specific issues on which they lobby.
Gain an informational edge with our Lobbying Data Intelligence. Perform analysis by company, lobbyist, lobbying firm, government agency, or issue.
For lobbying firms: understand your competitors. Understand who is registering with who. Gain insight on quarterly reports and specific issues other firms are lobbying on.
Our lobbying data is collected and aggregated from the U.S. Senate Office of Public Records from 1999-present and is updated on a regular basis. We utilize advanced data science techniques to ensure accurate data points are collected and ingested, match similar entities across time, and tickerize publicly traded companies that lobby.
Our comprehensive and advanced lobbying database is completed with all the information you need, with more than 1.6 million lobbying contracts ready-for-analysis. We include detailed information on all aspects of federal lobbying, including the following fascinating attributes, among much more:
1. Clients: The publicly traded company, privately owned company, interest group, NGO, or state or local government that employs or retains a lobbyist or lobbying firm.
2. Registrants (Lobbying Firms): Either the name of the lobbying firm hired by the client, or the name of the client if the client employs in-house lobbyists.
3. Lobbyists: The names and past government work experience of the individual lobbyists working on a lobbying contract. 3. General Issues: The general issues for which clients lobby on (ex: ENV – Environment, TOB – Tobacco, FAM – Family Issues/Abortion).
4. Specific Issues: A long text description of the exact bills and specific issues for which clients lobby on.
5. Bills Lobbied On: The exact congressional bills and public/private laws lobbied on, parsed from lobbying report specific issues (ex: H.R. 2347, S. 1117, Tax Cuts and Jobs Act).
6. Agencies Lobbied: The names of one or more of 250+ government agencies lobbied on in the contract (ex: White House, FDA, DOD).
7. Foreign Entities: The names and origin countries of entities affiliated with the client (ex: BNP Paribas: France).
Gain access to our highly unique and actionable U.S. lobbying database. Further information on LobbyingData.com and our alternative datasets and database can be found on our website, or by contacting [email protected].
Frequently Asked Questions
What is Ascendis Pharma, Inc. (ASND) lobbying for?
Summary of lobbying data for Ascendis Pharma, Inc.:
– Lobbying firms hired: Ascendis Pharma, Rubicon Advisors, Llc, Inc.
– General issues they lobbied on: Pharmacy
– Specific issues they lobbied on:
1. Orphan Drugs
2. Food and Drug Administration
3. Rare disease issues. Orphan drugs.
4. Prescription Drug User Fee (PDUFA) reauthorization.
5. Biosimilar User Fee Act (BsUFA) reauthorization.
– Government agencies they lobbied: Senate, Food & Drug Administration (FDA), Natl Institutes of Health (NIH), House of Representatives
One could infer that Ascendis Pharma, Inc. is lobbying on these issues because they are a pharmaceutical company that specializes in developing therapies for rare diseases, including orphan drugs – medications that treat rare diseases affecting fewer than 200,000 people in the U.S. As such, they are likely advocating for more favorable policies and regulations from the FDA and NIH that would facilitate the development, approval, and funding of their drugs. The PDUFA and BsUFA reauthorizations are important legislation that allocate funding and establish timelines for drug approval processes, which can significantly impact the pharmaceutical industry. Overall, Ascendis Pharma, Inc. is likely lobbying to strengthen their presence and support within the U.S. pharmaceutical industry, as well as to improve access to their treatments for patients with rare diseases.
